Injectable calcium sulfate bone graft enters US
This article was originally published in Clinica
Executive Summary
Wright Medical has launched in the US a calcium sulfate-based bone graft that can be injected into bone voids or fractures with minimal surgical exposure. The product is entering a market estimated at 270,000 distal radius, tibial plateau, calcaneus, pilon and other fractures.